with the full acquisition of cameron health in june 2012 the company also became notable for offering a minimally invasive implantable cardioverter defibrillator icd which they call the emblem subcutaneous implantable defibrillator s icd boston scientific was formed june 29 1979 in watertown massachusetts as a holding company for a medical products company called medi tech and to position the company for growth in interventional medicine the company went public through an initial public offering on may 19 1992 the taxus stent was approved in 2003 in europe and other countries and approved in the united states by the fda in march 2004 it was the second drug eluting stent approved in the united states in april 2004 the company announced that it had exercised an exclusive option to acquire precision vascular systems inc as part of a series of agreements between boston scientific and precision vascular in 2002 for an undisclosed sum in june boston acquired advanced bionics corporation for 740 million in cash plus earn out payments in december boston completed its acquisition of advanced stent technologies inc for 120 million payable in boston scientific stock plus the possibility of future contingent payments ast had been developing stent